{"id":41520,"date":"2025-04-18T20:34:46","date_gmt":"2025-04-18T15:04:46","guid":{"rendered":"https:\/\/www.nextias.com\/ca\/?p=41520"},"modified":"2025-04-18T20:35:11","modified_gmt":"2025-04-18T15:05:11","slug":"india-global-pharmaceutical-footprint","status":"publish","type":"post","link":"https:\/\/www.nextias.com\/ca\/current-affairs\/18-04-2025\/india-global-pharmaceutical-footprint","title":{"rendered":"India&#8217;s Global Pharmaceutical Footprint"},"content":{"rendered":"\n<p><strong>Syllabus: GS3\/ Economy<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Context<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The Department of Pharmaceuticals, with a vision to make India the world\u2019s largest provider of quality medicines at reasonable prices, transformed the country\u2019s global pharmaceutical footprint.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Pharmaceutical Sector of India<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>India\u2019s pharmaceutical market for <strong>FY 2023-24 <\/strong>is valued at <strong>USD 50 billion<\/strong> with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion.<\/li>\n\n\n\n<li><strong>Major segments of industry<\/strong> include generic drugs, OTC medicines, bulk drugs, vaccines, contract research &amp; manufacturing, biosimilars and biologics.\u00a0<\/li>\n\n\n\n<li>The Pharma sector currently contributes to around <strong>1.72% of the country\u2019s GDP.<\/strong><\/li>\n\n\n\n<li>India is the <strong>3rd largest producer of API <\/strong>accounting for an<strong> 8% share <\/strong>of the Global API Industry.\u00a0<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img data-dominant-color=\"b5cad7\" data-has-transparency=\"true\" style=\"--dominant-color: #b5cad7;\" loading=\"lazy\" decoding=\"async\" width=\"434\" height=\"443\" src=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/04\/india-pharmacy-of-the-world.png\" alt=\"india pharmacy of the world\" class=\"has-transparency wp-image-41522\" srcset=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/04\/india-pharmacy-of-the-world.png 434w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/04\/india-pharmacy-of-the-world-294x300.png 294w\" sizes=\"auto, (max-width: 434px) 100vw, 434px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>Achievements of Pharmaceutical Sector of India<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>India has been UNICEF\u2019s largest vaccine supplier for the past six to seven years, contributing <strong>55% to 60%<\/strong> of total volume procured.<\/li>\n\n\n\n<li>India is also\u00a0 contributing <strong>99%, 52% and 45%<\/strong> of the WHO demand for <strong>DPT, BCG and the measles vaccines<\/strong>, respectively.<\/li>\n\n\n\n<li><strong>The cumulative FDI equity inflow<\/strong> in the Drugs and Pharmaceuticals industry is <strong>US$ 22.52 billion<\/strong> during the period 2000-2024.<\/li>\n\n\n\n<li>The nation is the <strong>largest provider of generic medicines<\/strong> globally, occupying a <strong>20% share<\/strong> in global supply by volume, and is the leading vaccine manufacturer globally.\n<ul class=\"wp-block-list\">\n<li>India is known as the &#8220;<strong>pharmacy of the world&#8221; <\/strong>due to the low cost and high quality of its medicines.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Medical Devices sector<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The medical devices sector is an essential and integral constituent of the Indian healthcare sector, particularly for <strong>prevention, diagnosis, treatment and management<\/strong> of all medical conditions and disabilities.<\/li>\n\n\n\n<li><strong>Its constituent device categories are<\/strong>; Electro-medical equipment, implants, consumables and disposables, surgical instruments and in vitro diagnostic reagents.<\/li>\n\n\n\n<li>In the financial year of 2024-25, from April 2024 to December 2024, FDI inflows (in both pharmaceuticals and medical devices) was <strong>\u20b911,888 Crore.<\/strong><\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img data-dominant-color=\"88b0c5\" data-has-transparency=\"true\" style=\"--dominant-color: #88b0c5;\" loading=\"lazy\" decoding=\"async\" width=\"404\" height=\"532\" src=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/04\/foreign-direct-investment.png\" alt=\"foreign direct investment\" class=\"has-transparency wp-image-41521\" srcset=\"https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/04\/foreign-direct-investment.png 404w, https:\/\/wp-images.nextias.com\/cdn-cgi\/image\/format=auto\/ca\/uploads\/2025\/04\/foreign-direct-investment-228x300.png 228w\" sizes=\"auto, (max-width: 404px) 100vw, 404px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\"><strong>Government initiatives<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Production Linked Incentive Scheme, <\/strong>launched in 2020, is a transformative initiative aimed at boosting domestic manufacturing, attracting investments, reducing reliance on imports and increasing exports. It includes;\n<ul class=\"wp-block-list\">\n<li>PLI Scheme for Pharmaceuticals,<\/li>\n\n\n\n<li>PLI Scheme for promotion of domestic manufacturing of critical KSMs\/DIs\/APIs,<\/li>\n\n\n\n<li>PLI Scheme for promoting domestic manufacturing of Medical Devices.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Promotion of Bulk Drug Parks: <\/strong>Approved in March 2020, the scheme (FY 2020\u201321 to FY 2025\u201326) aims to establish parks with world-class common infrastructure to reduce manufacturing costs and enhance self-reliance in bulk drugs.\u00a0<\/li>\n\n\n\n<li><strong>Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP): <\/strong>Quality generic medicines are made available at affordable prices to all through dedicated outlets.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Concluding remarks<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>India&#8217;s pharmaceutical and medical devices sectors stand as a testament to the country\u2019s growing capabilities in science, innovation, and manufacturing.<\/li>\n\n\n\n<li>It has stressed that the country\u2019s pharmaceutical sector will touch the <strong>130 billion<\/strong> US dollar mark by <strong>2030.<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Sources: <\/strong><a href=\"https:\/\/pib.gov.in\/PressReleaseIframePage.aspx?PRID=2121425#_ftn2\" rel=\"nofollow noopener\" target=\"_blank\"><strong>PIB<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<h3><strong>Context<\/strong><\/h3>\n<li class=\"ms-5\">The Department of Pharmaceuticals, with a vision to make India the world\u2019s largest provider of quality medicines at reasonable prices, transformed the country\u2019s global pharmaceutical footprint.<\/li>\n<p><\/p>\n<h3><strong>Pharmaceutical Sector of India<\/strong><\/h3>\n<li class=\"ms-5\">India\u2019s pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion.<\/li>\n<li class=\"ms-5\">Major segments of industry include generic drugs, OTC medicines, bulk drugs, vaccines, contract research &#038; manufacturing, biosimilars and biologics.\u00a0<\/li>\n<p><a href=\"https:\/\/www.nextias.com\/ca\/current-affairs\/18-04-2025\/india-global-pharmaceutical-footprint\" class=\"btn btn-primary btn-sm float-end\">Read More<\/a><\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-41520","post","type-post","status-publish","format-standard","hentry","category-current-affairs"],"acf":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/41520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/comments?post=41520"}],"version-history":[{"count":2,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/41520\/revisions"}],"predecessor-version":[{"id":41550,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/41520\/revisions\/41550"}],"wp:attachment":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/media?parent=41520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/categories?post=41520"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/tags?post=41520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}